Table 3 Patient data, status and treatment results from MRI scans and from histopathology
MRI | Histopathology | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Pat.-No. | Age | Clinical status | Resection | Pre- to post-ILP contrast medium enhancement (%) | Max. tumour diameter (mm) before TM-ILP | Tumour depth (mm) | Pre- to post-ILP MRI tumour-volume (%) | Grade of regression (Salzer–Kuntschik) | Histopathologic regression (%) | Entity |
1 | 46 | No local recurrence | Resection | 25 | 115 | 9 | 55 | 1 | 100 | Undifferentiated pleomorphic sarcoma |
2 | 61 | Late progressive disease | No resection | 50 | 53 | 17 | 61 | Fibrosarcoma | ||
3 | 75 | No local recurrence | Resection | 100 | 119 | 8 | 60 | 5 | 5 | Dedifferentiated liposarcoma |
4 | 76 | Systemic progression of disease | No resection | 25 | 66 | 2 | 63 | Synovial sarcoma | ||
5 | 44 | No local recurrence | Resection | 90 | 111 | 10 | 93 | 4 | 80 | Myxoid round cell liposarcoma |
6 | 59 | No local recurrence | Resection | 100 | 42 | 2 | 102 | 3 | 93 | Undifferentiated pleomorphic sarcoma of the inflammatory type |
7 | 68 | Late local recurrence | No resection | 50 | 19 | 6 | 22 | Fibroblastic sarcoma | ||
8 | 82 | Tumour-related death | No resection | 25 | 37 | 1 | 43 | Undifferentiated pleomorphic sarcoma (spindle cell) | ||
9 | 44 | Lost to follow-up | — | Lost to follow-up | — | 7 | Undifferentiated pleomorphic sarcoma | |||
10 | 52 | Local recurrence | Resection | 50 | 68 | 3 | 103 | 3 | 93 | Squamous cell carcinoma |
11 | 80 | Ongoing complete remission | No resection | 90 | 25 | 3 | 36 | Malignant melanoma | ||
Mean | 61 | 66 | 6 | 64 | 74 | |||||
Median | 50 | 60 | 6 | 61 | 93 | |||||
Minimum | 25 | 19 | 1 | 22 | 5 | |||||
Maximum | 100 | 119 | 17 | 103 | 100 | |||||
SD | 31.6 | 37.6 | 4.8 | 27.7 | 39.4 | |||||
